TRV GP IV, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
TRV GP IV, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,403,604
+34.5%
2,343,1540.0%3.92%
-43.9%
Q2 2023$7,732,408
+15.8%
2,343,1540.0%6.99%
+46.4%
Q1 2023$6,677,989
-60.9%
2,343,1540.0%4.77%
-34.2%
Q4 2022$17,058,161
-10.0%
2,343,1540.0%7.25%
-34.5%
Q3 2022$18,956,000
+65.1%
2,343,1540.0%11.08%
+46.7%
Q2 2022$11,481,000
-79.3%
2,343,1540.0%7.55%
-62.8%
Q1 2022$55,416,000
+33.7%
2,343,1540.0%20.30%
+70.3%
Q4 2021$41,450,000
-37.3%
2,343,1540.0%11.92%
-20.5%
Q3 2021$66,100,000
+169.2%
2,343,1540.0%15.00%
+28.3%
Q2 2021$24,556,000
-11.0%
2,343,1540.0%11.69%
+15.0%
Q1 2021$27,602,000
+0.6%
2,343,1540.0%10.17%
+15.5%
Q4 2020$27,438,000
+47.7%
2,343,1540.0%8.80%
+37.6%
Q3 2020$18,581,000
-56.6%
2,343,1540.0%6.40%
-67.6%
Q2 2020$42,856,000
+53.2%
2,343,1540.0%19.74%
-22.8%
Q1 2020$27,977,000
-28.2%
2,343,1540.0%25.58%
+5.2%
Q4 2019$38,990,000
+150.6%
2,343,1540.0%24.31%
+52.7%
Q3 2019$15,559,0002,343,15415.92%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders